Skip to main content
OpenTrials
Completed

NCT Number: NCT02708459

Transversus Abdominus Plane Block in Living Donor Hepatectomy

Comparing different drugs used in Transversus abdominus plane analgesia after donor hepatectomy. Patients will be divided into three groups; control group, Bupivecaine group, and Dexmedetomedine group according to the used drug

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Living Donor Hepatectomy

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura university, Al Mansurah, Dakahlia Governorate, Egypt

Loading trial locations.

About this study

Transversus abdominus plane block for postoperative analgesia after donor hpatectomy surgery using three different drugs control group, Bupivecaine group, and Dexmedetomedine group

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all living hepatectomy donors in Mansoura liver transplantation program

Exclusion criteria

  • refusal known sensetivity to used drugs

Treatment and study plan

surgically inserted Transversus abdominus plane catheter

Device

at end of surgery, a surgeon will insert catheter in Transversus abdominus plane (TAP) between internal oblique muscle and Transversus abdominus muscle

intravenous morphine

Drug

Boluses of intravenous morphine (2 mg) will be given to patients if Visual analogue scale (VAS) more than 3

Bupevecaine

Drug

dexmedetomedine

Drug

Primary outcomes

  1. postoperative morphine (mg) consumption in 1st 48 hours

    Time frame: 48 hours postoperative

Sponsors and collaborators

Lead sponsor

AlRefaey Kandeel

Other

Registry information

Acronym: TAP Donor

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Mar 15, 2016
Registry last updated
Aug 30, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.